written by reader immunotherapy company

by bobmc100 | January 29, 2021 2:30 pm

What is the small cap company being pitched by Ian King[1]. Says its a $409 Million company that recently received FDA[2] approval for the treatment of respiratory inflammation[3] in coviid patients.

Endnotes:
  1. Ian King: https://www.stockgumshoe.com/tag/ian-king/
  2. FDA: https://www.stockgumshoe.com/tag/fda/
  3. inflammation: https://www.stockgumshoe.com/tag/inflammation/

Source URL: https://www.stockgumshoe.com/2021/01/microblog-immunotherapy-company/


2 responses to “written by reader immunotherapy company”

  1. rferr48792 says:

    Ampion, AMPE is a company working on FDA approval for their drug. Don’t think they’ve actually received FDA final approval yet…
    In trials in both the US and Israel with good results to date. They are doing trials on an injectable and a nebulized delivery (inhaler)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.